×

Lack of association of mortalin (HSPA9) and other mitochondria-related genes with risk of Parkinson's and Alzheimer's diseases.

Lackof association of mortalin (HSPA9) and other mitochondria-related genes with risk of Parkinson's and Alzheimer's diseases

Mortality of advanced Parkinson’s disease patients treated with deep brain stimulation surgery

Sensory Tricks for CervicalLevodopa-induced Dyskinesia in Patients with Parkinson’s Disease

Alpha-Synuclein in Gastric and Colonic Mucosa in Parkinson's Disease: Limited Role as a Biomarker

Association of type 2 diabetes GWAS loci and the risk of Parkinson’s and Alzheimer’s disease

Clinical features of drug-induced parkinsonism based on [18F] FP-CIT positron emission tomography

Risk Factors Associated With the Presence of Unruptured Intracranial Aneurysms

Development and validation of effective real-time and periodic interinstrument comparison method for automatic hematology analyzers.

Gait freezing and speech disturbance in Parkinson's disease.

The Sysmex XN-2000 hematology autoanalyzer provides a highly accurate platelet count than the former Sysmex XE-2100 system based on comparison with the CD41/CD61 immunoplatelet reference method of flow cytometry.

Clinical features and nigrostriatal dysfunction in patients with combined postural and resting tremors

Cerebellar Degeneration Associated with Sj?gren's Syndrome.

Long-term outcome of cap polyposis, with special reference to the effects of steroid therapy.

A Case of Isolated Ileal Ganglioneuroma

Lateralized effects of unilateral thalamotomy and thalamic stimulation in patients with essential tremor.

Effect of thalamotomy familial hand dystonia with DYT1 mutation

Evaluation of the TEST 1 erythrocyte sedimentation rate system and intra- and inter-laboratory quality control using new latex control materials.

Homocysteine-lowering therapy or antioxidant therapy for bone loss in Parkinson's disease

Homocysteine-lowering therapy or antioxidant therapy for bone loss in Parkinson's disease Movement disorders

Hyperhomocysteinemia due to levodopa treatment as a risk factor for osteoporosis in patients with Parkinson's disease

Hyperhomocysteinemia due to levodopa treatment as a risk factor for osteoporosis in patients with Parkinson's disease.

Freezing of Gait and Cognitive Functions in Patients with Parkinson’s Disease, Dementia and Neurocognitive Disorders.

Functional brain imaging in pure akinesia with gait freezing: [18F] FDG PET and [18F] FP-CIT PET analyses

Functional brain imaging in pure akinesia with gait freezing: [18F] FDG PET and [18F] FP-CIT PET analyses.

Acoustic neuroma presenting with a resting tremor

Acoustic neuroma presenting with a resting tremor.

Determining Factors for the Reduction of Dopaminergic Drugs after Bilateral Subthalamic Nucleus Deep Brain stimulation.

Marked diurnal fluctuation and rest benefit in a patient with parkin mutation.

Marked diurnal fluctuation and rest benefit in a with Parkin mutation